Anastasia M. Fernands

Anastasia M. Fernands is an accomplished patent litigator with a focus on complex intellectual property disputes, particularly within the life sciences sector. Her practice centers on pharmaceutical formulations, medical devices, and biotechnology, including Hatch-Waxman actions and cases involving gene therapies and therapeutic antibodies. Beyond life sciences, Ms. Fernands has experience across diverse technologies such as smartphones, e-commerce, white LEDs, and set-top box technologies. She is noted for her comprehensive approach to patent litigation, encompassing pre-suit investigations, discovery, and trial preparation.

Based on tracked appearances, Ms. Fernands has primarily represented plaintiffs in patent litigation, with nine plaintiff-side appearances and one defendant-side appearance. However, her firm profile indicates extensive experience representing both plaintiffs and defendants. She is currently of counsel in Quinn Emanuel Urquhart & Sullivan's New York office, having joined the firm in 2007. Her prior experience includes practicing at Goodwin Procter and Hutchins, Wheeler and Dittmar in Boston.

Ms. Fernands has been involved in several prominent patent litigation matters. She was a member of the team representing Samsung in the high-profile patent litigations against Apple concerning smartphone and tablet technology. She has also played a key role in pharmaceutical patent disputes, including representing Veloxis Pharmaceuticals, Inc. as a plaintiff in cases against Sun Pharmaceutical Industries Ltd. and Accord Healthcare, Inc. Notably, she represented Sarepta Therapeutics, Inc. as a defendant in Genzyme Corp. v. Sarepta Therapeutics, Inc., a case involving gene therapies for muscular dystrophy. Additionally, she has represented Halozyme, Inc. in litigation against Merck Sharp & Dohme Corp. and Vivus, Inc. in Hatch-Waxman actions.

Her experience extends to proceedings before the Patent Trial and Appeal Board (PTAB), as evidenced by her involvement in the Halozyme, Inc. v. Merck Sharp & Dohme Corp. matter, which included a Final Written Decision from the PTAB. Ms. Fernands earned her J.D. from New York University School of Law in 1996 and completed her undergraduate studies at Harvard. She is based in Quinn Emanuel's New York office.